Clinical Trial Update: Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subcutaneous piperacillin/tazobactam versus intravenous therapy; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Zosyn (Piperacillin/tazobactam)

Snippet

Sponsor: Azienda Sanitaria Universitaria Friuli Centrale | Conditions: Bacteria Infection, Piperacillin, Tazobactam Drug Combination | Phase 2 | Status: RECRUITING